Summary by Futu AI
Four Circle Pharmaceutical Holdings Group Limited (“Four Circle Pharmaceuticals”) informed shareholders on 29 April 2024 that the Company's 2023 Annual Report, Circular and Proxy Form (the “Company Newsletter”) and 2023 Environmental, Social and Governance Report (the “ESG Report 2023”) have been published. The Chinese and English versions of these documents are available on the Company's website and on the HKEX's easily disclosed website. The Company has provided a Change Request Form for shareholders to choose the language version and method of receipt of the Company's communication documents in the future. Shareholders who experience difficulties in receiving or accessing the Company's communications documents may request a free printed copy. In addition, shareholders may change the language version or manner of receipt of the Company's communications at any time and may notify the Share Registrar by email or in writing. THE COMPANY EMPHASIZES THAT IF SHAREHOLDERS HAVE ANY QUESTIONS ABOUT THIS, THEY CAN CONTACT THE SHARE TRANSFER OFFICE DURING BUSINESS HOURS.